冠心病患者血浆白细胞介素-35水平及临床意义的探讨

台适, 周胜华, 刘启明, 等. 冠心病患者血浆白细胞介素-35水平及临床意义的探讨[J]. 临床心血管病杂志, 2014, 30(1): 81-84. doi: 10.13201/j.issn.1001-1439.2014.01.025
引用本文: 台适, 周胜华, 刘启明, 等. 冠心病患者血浆白细胞介素-35水平及临床意义的探讨[J]. 临床心血管病杂志, 2014, 30(1): 81-84. doi: 10.13201/j.issn.1001-1439.2014.01.025
TAI Shi, ZHOU Shenghua, LIU Qiming, et al. The plasma IL-35 levels in patients with coronary heart disease and its clinical significance[J]. J Clin Cardiol, 2014, 30(1): 81-84. doi: 10.13201/j.issn.1001-1439.2014.01.025
Citation: TAI Shi, ZHOU Shenghua, LIU Qiming, et al. The plasma IL-35 levels in patients with coronary heart disease and its clinical significance[J]. J Clin Cardiol, 2014, 30(1): 81-84. doi: 10.13201/j.issn.1001-1439.2014.01.025

冠心病患者血浆白细胞介素-35水平及临床意义的探讨

详细信息
    通讯作者: 周胜华, E-mail:zhoushenghua_guo@163.com
  • 中图分类号: R541.4

The plasma IL-35 levels in patients with coronary heart disease and its clinical significance

More Information
  • 加载中
  • [1]

    FROSTEGARD J, ULFGREN A K, NYBERG P, et al.Cytokine expression in advanced human atherosclerotic plaques:dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines[J].Atherosclerosis, 1999, 145:33-43.

    [2]

    ALAM S E, NASSER S S, FERNAINY K E, et al.Cytokine imbalance in acute coronary syndrome[J].Curr Opin Pharmacol, 2004, 4:166-170.

    [3]

    TEDGUI A, MALLAT Z.Cytokines in atherosclerosis:pathogenic and regulatory pathways[J].Physiol Rev, 2006, 86:515-581.

    [4]

    NIEDBALA W, WEI X Q, CAI B, et al.IL-35is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells[J].Eur J Immunol, 2007, 37:3021-3029.

    [5]

    COLLISON L W, WORKMAN C J, KUO T T, et al.The inhibitory cytokine IL-35contributes to regulatory T-cell function[J].Nature, 2007, 450:566-569.

    [6]

    LI X, MAI J, VIRTUE A, et al.IL-35is a novel responsive anti-inflammatory cytokine——a new system of categorizing anti-inflammatory cytokines[J].PLoS One, 2012, 7:e33628-33628.

    [7]

    KOCHETKOVA I, GOLDEN S, HOLDERNESS K, et al.IL-35stimulation of CD39+ regulatory T cells confers protection against collagenⅡ-induced arthritis via the production of IL-10[J].J Immunol, 2010, 184:7144-7153.

    [8]

    KEMPE S, HEINZ P, KOKAI E, et al.Epstein-barr virus-induced gene-3is expressed in human atheroma plaques[J].Am J Pathol, 2009, 175:440-447.

    [9]

    GENSINI G G.A more meaningful scoring system for determining the severity of coronary heart disease[J].Am J Cardiol, 1983, 51:606-608.

    [10]

    LEE T S, YEN H C, PAN C C, et al.The role of interleukin 12in the development of atherosclerosis in ApoE-deficient mice[J].Arterioscler Thromb Vasc Biol, 1999, 19:734-742.

    [11]

    CAO Y, DOODES P D, GLANT T T, et al.IL-27 induces a Th1 immune response and susceptibility to experimental arthritis[J].J Immunol, 2008, 180:922-930.

    [12]

    TASSI E, BRAGA M, LONGHI R, et al.Non-redundant role for IL-12and IL-27in modulating Th2 polarization of carcinoembryonic antigen specific CD4 T cells from pancreatic cancer patients[J].PLoS One, 2009, 4:e7234-7234.

    [13]

    BICKERSTAFF A, OROSZ C.Evidence for a limited contribution of immune regulation to cardiac allograft acceptance[J].Hum Immunol, 2002, 63:935-947.

    [14]

    FEINBERG M W, JAIN M K, WERNER F, et al.Transforming growth factor-beta 1inhibits cytokinemediated induction of human metalloelastase in macrophages[J].J Biol Chem, 2000, 275:25766-25773.

    [15]

    张文宗, 林钟香.转化生长因子-β1在冠心病中的研究进展[J].实用医学杂志, 2008, 7 (21):3779-3781.

    [16]

    LINDMARK E, TENNO T, CHEN J, et al.IL-10inhibits LPS-induced human monocyte tissue factor expression in whole blood[J].Br J Haematol, 1998, 102:597-604.

    [17]

    LIN Y, HUANG Y, LU Z, et al.Decreased plasma IL-35levels are related to the left ventricular ejection fraction in coronary artery diseases[J].PLoS One, 2012, 7:e52490-52490.

  • 加载中
计量
  • 文章访问数:  29
  • PDF下载数:  18
  • 施引文献:  0
出版历程
收稿日期:  2013-07-29

目录